AI evidence summary · MVP

Iron for Iron Deficiency Anemia

AI research summary · not rated

Research results

Findings are currently provided in Traditional Chinese; source excerpts retain their original language.

Retrieval is incomplete. These results do not represent all relevant research.

Research finding 1

21 days to 6 months

在缺鐵的非血液透析依賴型慢性腎臟病患者中,靜脈鐵相較口服鐵可顯著提高血清鐵蛋白與轉鐵蛋白飽和度,但血紅素並未一致升高。

追蹤期介於 21 天至 6 個月,部分患者同時使用促紅細胞生成劑,且不確定是否所有人都符合缺鐵性貧血。

Applicability remains unclear. 涉及非血液透析依賴性CKD患者的缺鐵治療及靜脈與口服鐵比較;部分患者同時接受促紅細胞生成劑,且是否全部符合缺鐵性貧血未明確,因此適用性不確定。

Population
non-hemodialysis-dependent patients with chronic kidney disease and iron deficiency
Intervention
intravenous iron
Comparator
oral iron
Outcome
hemoglobin, ferritin, and transferrin saturation
Follow-up
21 days to 6 months
Formulation
intravenous iron versus oral iron; specific formulations not reported
Dose
Not established
Source excerpt: While studies found that i.v. iron significantly increased serum levels of ferritin and TSAT, hemoglobin levels were not consistently raised.
View source

Research finding 2

在發炎性腸病合併缺鐵性貧血患者中,只有靜脈注射羧基麥芽糖鐵的治療反應顯著優於口服鐵(OR=1.9,95% CrI:1.1–3.2);治療反應定義為血紅素恢復正常或增加至少 2 g/dL。

來源未報告此結果的劑量與時間點,且研究族群限於發炎性腸病患者。

Relevant to the question; some study details remain unknown. 直接涉及患有缺鐵性貧血的成人IBD患者,並比較靜脈羧基麥芽糖鐵與口服鐵;人群雖限於IBD,但屬於目標人群。

Population
patients with inflammatory bowel disease and iron deficiency anemia
Intervention
intravenous ferric carboxymaltose
Comparator
oral iron
Outcome
therapy response, defined as hemoglobin normalization or increase ≥2 g/dL
Follow-up
Not established
Formulation
intravenous ferric carboxymaltose
Dose
Not established
Source excerpt: Only ferric carboxymaltose was significantly more effective than oral iron [OR=1.9, 95% CrI: (1.1;3.2)].
View source

Research finding 3

3 weeks for ferritin; 4 and 6 weeks for hemoglobin

在妊娠期缺鐵性貧血研究中,Bhavi 與 Jaju 的兩組受試者於第 4 週血紅素分別上升 22 與 12 g/L。

短引文未交代 22 與 12 g/L 各對應靜脈鐵或口服鐵哪一組,因此不可判定組別差異;另述鐵蛋白增加 332.4,但單位與句尾缺失,故未納入結果句。

Relevant to the question; some study details remain unknown. 直接涉及妊娠期缺鐵性貧血及靜脈與口服鐵比較,但結果來自特定孕婦試驗,不能無條件推廣至所有患者。

Population
pregnant women with iron-deficiency anemia
Intervention
intravenous iron
Comparator
oral iron
Outcome
hemoglobin and ferritin
Follow-up
3 weeks for ferritin; 4 and 6 weeks for hemoglobin
Formulation
intravenous iron versus oral iron; specific formulations not stated in the quoted passage
Dose
Not established
Source excerpt: hemoglobin rose by 22 versus 12 g/L at four weeks in Bhavi and Jaju [1], while in Chawla et al. [6], ferritin increased by 332.4
View source

What remains unknown

  • A proposed finding could not be traced to a source passage.

Sources consulted

  1. Intravenous versus oral iron for treatment of iron deficiency in non-hemodialysis-dependent patients with chronic kidney disease. Abstract only · 2026-09-09T16:33:39.651046Z
  2. Systematic review with network meta-analysis: comparative efficacy and tolerability of different intravenous iron formulations for the treatment of iron deficiency anaemia in patients with inflammatory bowel disease. Abstract only · 2026-09-09T16:33:39.652047Z
  3. Intravenous and Oral Iron Strategies for Iron-Deficiency Anemia in Pregnancy: A Systematic Review of Randomized Controlled Trials From a Hematology Perspective. Full text · 2026-09-09T16:33:44.058818Z

Reading and assessment notes

This AI research summary has not been assigned an overall grade. Learn how summaries and ratings differ.

Absence of reported harms does not establish safety. This summary does not provide individual treatment or dosing advice.

Data and assessment record

Processing record

Search or processing incomplete

Sources through:2026-09-09 · Generated:2026-09-10T03:31:47.269048Z

Retrieved 20 records · Screened 20 · Included 3 reports · Omitted 7

Run:pilot-r8-20260909T163333Z

codex_cli / gpt-5.6-sol / automated-mvp-live-v1

{
  "included": 3,
  "limits_hit": [
    "search_result_window",
    "candidates",
    "fulltexts",
    "llm_source_payload"
  ],
  "omitted": 7,
  "retrieved": 20,
  "screened": 20
}

sha256:130ca82041e067d651690bea4964123bbced90748c9b9d8354eeac6971143cfb